Effect of Bosentan in Scleroderma Renal Crisis

PHASE2CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

October 31, 2015

Study Completion Date

June 30, 2016

Conditions
Scleroderma Renal Crisis
Interventions
DRUG

Bosentan

Bosentan 62.5mg bid x 4 weeks; up-titrated to 125mg bid x 20 weeks

Trial Locations (1)

75014

Pôle de médecine interne Centre de référence Maladies rares Groupe I Maladies systémiques et maladies auto-immunes rares en particulier Vascularites nécrosantes et les sclérodermies - Hôpital Cochin, Paris

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Actelion

INDUSTRY

lead

Assistance Publique - Hôpitaux de Paris

OTHER